
Check-Cap Ltd. CHEK
Geschäftsbericht 2024
hinzugefügt 21.02.2026
Check-Cap Ltd. Abschreibung & Amortisation 2011-2026 | CHEK
Abschreibung & Amortisation Jährlich Check-Cap Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 161 K | 212 K | 404 K | 205 K | 148 K | 115 K | 147 K | 157 K | 130 K | 92 K | 78 K | 77 K | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 404 K | 77 K | 160 K |
Abschreibung & Amortisation anderer Aktien in der Diagnostik & Forschung
| Name | Abschreibung & Amortisation | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 29.0 | -3.07 % | $ 316 M | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
14 M | $ 1.14 | -2.16 % | $ 1.45 M | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Celcuity
CELC
|
130 K | $ 104.95 | -1.72 % | $ 4.14 B | ||
|
Co-Diagnostics
CODX
|
1.23 M | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
721 M | $ 210.56 | -0.33 % | $ 154 B | ||
|
Castle Biosciences
CSTL
|
16 M | $ 29.41 | -6.17 % | $ 817 M | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Quest Diagnostics Incorporated
DGX
|
493 M | $ 202.21 | -0.11 % | $ 22.4 B | ||
|
DexCom
DXCM
|
252 M | $ 73.08 | 1.11 % | $ 28.5 B | ||
|
DarioHealth Corp.
DRIO
|
473 K | $ 11.75 | 2.8 % | $ 333 M | ||
|
CareDx, Inc
CDNA
|
14.4 M | $ 18.83 | -5.23 % | $ 1.01 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Illumina
ILMN
|
354 M | $ 117.53 | -2.06 % | $ 18.7 B | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 23.18 | -0.39 % | $ 701 M | ||
|
Exact Sciences Corporation
EXAS
|
125 M | $ 103.45 | 0.15 % | $ 19.5 B | ||
|
Lantheus Holdings
LNTH
|
64.6 M | $ 74.31 | 1.54 % | $ 5.14 B | ||
|
Guardant Health
GH
|
39.7 M | $ 103.36 | -2.84 % | $ 13 B | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 99.61 | 1.22 % | $ 8.22 B | ||
|
Interpace Biosciences
IDXG
|
300 K | $ 1.85 | 2.78 % | $ 8.12 M | ||
|
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 169.68 | 3.11 % | $ 8.41 B | ||
|
IDEXX Laboratories
IDXX
|
130 M | $ 635.6 | 0.77 % | $ 52.4 B | ||
|
IQVIA Holdings
IQV
|
1.14 B | $ 166.19 | -1.87 % | $ 28.6 B | ||
|
Biodesix
BDSX
|
5.77 M | $ 13.26 | 4.0 % | $ 1.72 B | ||
|
Laboratory Corporation of America Holdings
LH
|
644 M | $ 283.38 | 0.32 % | $ 23.8 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.17 | -2.25 % | $ 4.98 M | ||
|
Bioventus
BVS
|
57.4 M | $ 8.57 | -0.06 % | $ 537 M | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 452.99 | 1.47 % | $ 13.1 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
National Research Corporation
NRC
|
140 K | $ 13.65 | 9.64 % | $ 335 M | ||
|
Mettler-Toledo International
MTD
|
51.1 M | $ 1 378.44 | 0.14 % | $ 28.4 B |